Nouveaux antifongiques dans les candidoses et aspergilloses invasives
Diagnostic Strategy MicrobiologyHistologyAntigen(s) testingGlucansMolecular tools?. Which Antifungal?BioavailabilityPharmacokineticsDrug interactions Nephro-/Liver-toxicity. Patient CharacteristicsRenal/liver failureNeutropeniaChildren/elderly Previous antifungalsKnown colonization. Which Species (local epidemiology)?Candida albicans/non-albicansGlabrata/krusei vs.othersAspergillus fumigatus; others.
834 views • 34 slides